IQVIA Holdings has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-$15.58 billion. Retail sentiment entered extremely bullish territory (77/100) from a neutral zone supported by extremely high message volumes.
IQVIA Holdings Inc (NASDAQ:IQV) reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.
Latest Ratings for IQV
DateFirmActionFromTo Mar 2022MizuhoMaintainsBuy Feb...
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial...
IQVIA (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix...
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference...